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ABSTRACT
Intracellular invasion is an advantageous mechanism used by pathogens to evade host defense 
and antimicrobial therapy. In patients, the intracellular microbial lifestyle can lead to infection 
persistence and recurrence, thus worsening outcomes. Lung infections caused by Pseudomonas 
aeruginosa, especially in cystic fibrosis (CF) patients, are often aggravated by intracellular invasion 
and persistence of the pathogen. Proliferation of the infectious species relies on a continuous 
deoxyribonucleotide (dNTP) supply, for which the ribonucleotide reductase enzyme (RNR) is the 
unique provider. The large genome plasticity of P. aeruginosa and its ability to rapidly adapt to 
different environments are challenges for studying the pathophysiology associated with this type 
of infection.
Using different reference strains and clinical isolates of P. aeruginosa independently combined 
with alveolar (A549) and bronchial (16HBE14o- and CF-CFBE41o-) epithelial cells, we analyzed 
host–pathogen interactions and intracellular bacterial persistence with the aim of determining 
a cell type-directed infection promoted by the P. aeruginosa strains. The oscillations in cellular 
toxicity and oxygen consumption promoted by the intracellular persistence of the strains were 
also analyzed among the different infectious lung models. Significantly, we identified class II RNR 
as the enzyme that supplies dNTPs to intracellular P. aeruginosa. This discovery could contribute 
to the development of RNR-targeted strategies against the chronicity occurring in this type of 
lung infection.
Overall our study demonstrates that the choice of bacterial strain is critical to properly study 
the type of infectious process with relevant translational outcomes.
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Introduction
Laboratory reference strains fail to mimic in vivo bac-
terial infections [1]. Their high genome plasticity drives 
bacteria to rapidly adapt to the habitat where they grow 
[2]. Differences in sequence or genome size can be 
found in the same bacterial species depending on 
whether it has been isolated in situ from an infection 
or whether it comes from a laboratory collection after 
being passaged for decades under particular laboratory 
conditions [3]. Hence, the phenotype of a laboratory 
strain will rarely recreate the in vivo infectious envir-
onment [1].
Pseudomonas aeruginosa is a Gram-negative ubiqui-
tous bacterium that behaves as a nosocomial pathogen in 
humans. The large genome plasticity of P. aeruginosa 
confers it the ability to live in a wide range of environ-
ments, from a free-planktonic lifestyle to living in patho-
genic and disease environments [4]. The ability of 
P. aeruginosa to grow in very diverse environments and 
oxygen atmospheres is due in part to the different classes 
of ribonucleotide reductase (RNR) encoded in its genome: 
class Ia (nrdAB), II (nrdJab) and III (nrdDG) RNRs [5]. 
RNR is responsible for providing the deoxyribonucleo-
tides (dNTPs) required for DNA synthesis and repair; 
hence, it is an essential enzyme in all living cells. The 
requirements for generating the radical needed to per-
form catalysis differ among RNR classes. Class I RNR 
depends on oxygen to generate a tyrosyl radical; therefore, 
it is only active under aerobic conditions. Class II RNR 
uses 5ʹ-deoxyadenosylcobalamin to generate a cysteinyl 
radical and is oxygen independent. Finally, class III RNR 
requires strict anaerobic conditions to generate an oxy-
gen-sensitive glycyl radical using S-adenosylmethionine 
[6]. P. aeruginosa can balance the expression of the three 
known RNR classes to allow its growth in extremely 
distinct environments, which is an ability not shared 
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among bacteria and makes Pseudomonas a versatile and 
tenacious bacterium [5,6].
Under appropriate conditions, P. aeruginosa can cause 
an extensive variety of infections, such as bacterial kera-
titis, endocarditis, encephalocarditis, otitis, pneumonia, 
wound infections, and even septicemia. The lungs are 
specifically affected by this pathogen. In the lungs, 
Pseudomonas is able to cause both acute and chronic 
pneumonia [7]. Chronicity is caused by the capacity of 
P. aeruginosa to grow in highly protective and resistant 
communities called biofilms, as well as to promote cellu-
lar invasion as a mechanism to evade the host immune 
system [8,9]. People affected with life-threatening cystic 
fibrosis (CF) are particularly worried by this pathogen 
since it is responsible for the majority of morbidity and 
mortality associated with this disease [7–9].
A continuous supply of dNTPs is indispensable dur-
ing an infectious process. Marked oxygen deprivation 
in tissues is a signal of disease and infection [10]. In 
this study, we used the invasive PAO1 and cytotoxic 
PA14 laboratory strains together with different clinical 
CF isolates of P. aeruginosa to evaluate the differences 
in the intracellular persistence, and modulation of the 
expression of the RNR classes, during infection 
depending on the natural environmental background 
of the strain. The adenocarcinomic alveolar A549 cell 
line together with the bronchial 16HBE14o- and its CF- 
derived cell line CFBE41o- were the epithelial cell lines 
used in this study. CFBE41o- cells encode a stable 
∆F508 mutation in the CFTR gene to promote the CF 
phenotype. Furthermore, since the three lung epithelial 
cell lines are genetically and phenotypically different, 
for instance, high hypoxia levels have been found in the 
tumor-immortalized cell line A549 [11], while 
increases in reactive oxygen species production have 
been detected in CF-derived CFBE41o- cells [12], cell 
type-directed infection by a specific P. aeruginosa 
strain of a particular lung epithelial cell line was 
examined.
Our work demonstrates the differential cellular 
invasion, intracellular persistence, and oxygen con-
sumption patterns among the reference and clinical 
isolates of P. aeruginosa studied toward the different 
pulmonary epithelial cells. Thus, confirming different 
P. aeruginosa host-pathogen behaviors depending on 
the natural genetic background of the infectious bac-
teria. Significantly, by revealing a clear and marked 
transition from class Ia RNR during planktonic life to 
class II RNR expression during the intracellular per-
sistence of the bacterium among the different lung 
epithelial cell lines, this study identifies class II RNR 
as the dNTP supplier required for the P. aeruginosa 
intracellular lifestyle.
Materials and methods
Bacterial strains and growing conditions
In this study, we used the Pseudomonas aeruginosa 
PAO1 (CECT 4122/ATCC 15,692) and PA14 [13] refer-
ence laboratory wild-type strains and different cystic 
fibrosis isolates, PAET1, PAET2, and PAET4, which 
were isolated from recurrent infections of three differ-
ent chronic-infected patients [14]. The three different 
clinical isolates differed in the nature of infection they 
were isolated from: while PAET1 and PAET2 strains 
were isolated from patients that were not previously 
colonized, the PAET4 strain was isolated from a CF- 
patient that suffered from recurrent infections. In this 
sense, PAET1 and PAET2 could be treated as early 
isolates whereas PAET4 as a late P. aeruginosa clinical 
isolate. The isogenic nrdJ and nrdD mutants in the 
PAO1 strain were also used [15]. Overnight (O/N; 
~16 h) cultures of P. aeruginosa were routinely grown 
in Luria-Bertani medium (LB; Scharlab) at 37ºC with 
vigorous shaking. LB-agar (Scharlab) was used to count 
the respective bacterial colony forming units (CFU) of 
the P. aeruginosa strains.
Complementation of P. aeruginosa PAO1 ΔnrdJ 
and PAO1 ΔnrdD strains
To complement P. aeruginosa PAO1 ΔnrdJ strain, the 
encoding region of nrdJab gene from P. aeruginosa 
PAO1 was cloned into the BamHI sites of the 
pUCP20 T vector generating the pETS218 vector. 
Otherwise, for P. aeruginosa PAO1 ΔnrdD complemen-
tation, we used the pETS197 plasmid [14], which 
expresses the encoding region of PAO1’s nrdD gene. 
Each plasmid was electroporated inside the respective 
PAO1 ΔnrdJ and PAO1 ΔnrdD strain. Carbenicillin at 
300 ug/mL was used for plasmid maintenance.
Lung epithelial cells
Three different epithelial cell lines of the human airway 
were used in this study: adenocarcinomic alveolar A549 
(ATCC® CCL-185), bronchial 16HBE14o- and cystic 
fibrosis bronchial CFBE41o-. CFBE41o- epithelial cells 
are homozygous negative for the ∆F508 mutation of the 
CFTR gene [16]. For each set of experiments, a new vial 
was thawed, and cells were passaged no more than 10 
times. Cells were cultured in T-75 tissue culture flasks 
(Thermo Fisher Scientific) and grown in Dulbecco’s 
Modified Eagle Medium: Nutrient mixture F12 
(DMEM/F12; Thermo Fisher Scientific). Media were 
supplemented with 10% (v/v) decomplemented fetal 
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bovine serum (dFBS), 100 Units/mL penicillin and 100 
Units/mL streptomycin (Thermo Fisher Scientific). 
Cells were passaged and maintained in a humidified 
incubator at 37ºC and 5% (v/v) CO2 (ICOmed, 
Memmert).
P. aeruginosa adhesion, invasion and intracellular 
persistence in lung epithelial cells
A549, 16HBE14o-, and CFBE41o- cells were seeded 
into 24-well culture plates (SPL Life Sciences) at 
~7.5x104 cells/well and incubated for 48 h prior to O/ 
N incubation with antibiotic-free DMEM medium. 
Incubation without antibiotics was performed to ensure 
that possible traces of antibiotics that could interfere 
with the experiments were cleared. Infection with the 
different P. aeruginosa strains was performed at 
a multiplicity of infection (MOI) of 100 in antibiotic- 
free DMEM for 3 h. To determine bacterial adhesion 
(adhesion and invasion), cell monolayers were gently 
washed three times with warm 1x phosphate-buffered 
saline (PBS; pH 7.4) and lysed with 200 µl of PBS 
containing saponin (0.1% w/v; saponin buffer) for 
15 min. To quantify the intracellular invasion of the 
different P. aeruginosa strains, we used the gentamicin 
survival assay as previously described [17]. Briefly, after 
3 h of infection, monolayers were washed with warm 
1X PBS and then incubated with DMEM containing 
gentamicin 200 µg/mL (gentamicin solution) for 
90 min to kill extracellular P. aeruginosa. After incuba-
tion with the gentamicin solution, cells were washed 
with warm 1X PBS and subsequently lysed with the 
same volume of saponin buffer used for the adhesion 
evaluation. Serial dilutions were plated onto agar plates, 
and colony-forming units (CFU) were enumerated after 
incubation at 37ºC O/N. The invasion rate of each 
P. aeruginosa strain per cell was calculated as 
a percentage of the invaded CFU relative to that 
adhered.
To determine the intracellular growth of the differ-
ent P. aeruginosa strains inside the different lung 
epithelial cells, monolayers were infected at a MOI of 
1 for 3 h and then incubated with a gentamicin solu-
tion. Bacterial invasion was evaluated after 1.5 h, 3 h, 
4.5 h, 6 h, and 21 h of incubation at 37ºC. When the 
complemented P. aeruginosa PAO1 ΔnrdJ+pETS218 
and PAO1 ΔnrdD+ pETS197 were used, Cb 300 µg/ 
mL was added to the culture medium to ensure the 
maintenance of the plasmid. The slope of intracellular 
survival of each P. aeruginosa strain after 21 h of Gm 
treatment was calculated with the GraphPad Prism 8.0 
software.
Protein electrophoresis and staining
The P. aeruginosa protein expression patterns of the 
different strains were determined by sodium dodecyl 
sulfate–polyacrylamide (SDS-PAGE) gel electrophor-
esis. Briefly, 3 μg of total protein from the PAO1, 
PA14, PAET1, PAET2, and PAET4 strains grown 
under planktonic conditions for 3 and 24 h was loaded 
on a 10% SDS-PAGE gel. Protein quantification of each 
crude extract was determined by the Bradford assay 
(Bio-Rad). After electrophoresis, the gels were stained 
using PageBlueTM Staining Solution (Thermo Fisher 
Scientific) following the manufacturer’s instructions.
Western blot of Nrd proteins from P. aeruginosa
Western blotting was performed to analyze the differ-
ences in the intracellular expression of the NrdA, NrdJ, 
and NrdD proteins among the P. aeruginosa strains. 
Confluent monolayers of A549, 16HBE14o-, and 
CFBE41o- were infected with the P. aeruginosa refer-
ence PAO1 and PA14 strains in addition to the CF 
isolates PAET1, PAET2, and PAET4 strains at 
a MOI = 100 for 3 h. At the time point, each extra-
cellular fraction was centrifuged, and bacterial pellets 
were lysed with BugBuster extraction reagent 
(Novagen) following the manufacturer’s instructions. 
Otherwise, two different bacterial fractions were used 
to evaluate intracellular Nrd protein expression: one 
fraction was taken after 3 h of infection and the other 
fraction was taken after 24 h of intracellular persistence. 
To do so, infected monolayers were washed with warm 
1X PBS and incubated at 37ºC with a gentamicin solu-
tion for 90 min or for 21 h to kill extracellular bacteria. 
After incubation, cells were washed with 1X PBS, and 
monolayers were lysed with BugBuster lysis solution.
Five micrograms of total protein were separated by 
SDS-PAGE and electrotransferred onto polyvinylidene 
difluoride membranes. Detection of NrdA, NrdD, and 
NrdJ by Western blot analysis was performed as we 
previously described [5] using anti-NrdA, anti-NrdD, 
and anti-NrdJ (Agrisera, Sweden) antibodies at 
a 1:1000 dilution. Detection of primary antibodies 
was performed using a donkey antirabbit horseradish 
peroxidase-conjugated secondary antibody (Bio-Rad) 
at a 1:50,000 dilution. Immunodetection was per-
formed using the AmershamTM ECLTM Prime 
Western blotting reagent (GE Healthcare) according 
to the manufacturer’s instructions, and proteins were 
visualized using the ImageQuantTM LAS4000 mini 
system (GE Healthcare). Unspecific bands were used 
as loading controls. A pilot Western blot experiment 
using a crude protein extract of the lung monolayers 
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failed to detect the NrdA homologue in human RRM1 
(~90 kDa), thus confirming the specificity of the anti- 
NrdA antibody against the bacterial protein. NrdA 
(~107.1 kDa), NrdD (~76.1 kDa), and NrdJ (~82.7 
kDa) protein bands were selected according to the 
molecular weight given by the antibodies binding to 
purified NrdA, NrdD, and NrdJ proteins from our 
laboratory stock (Figure S1A). Unspecific protein 
bands from each Nrd protein immunoblot were used 
as a loading control (Figure S1B). Protein band ana-
lysis was performed using ImageQuantTM LAS4000 
software, and the average number of pixels of each 
Nrd protein band volume was used as relative to the 
levels of protein expression. To calculate the induction 
of each Nrd protein after 24 h of intracellular persis-
tence, the average number of pixels of each protein 
band was normalized by the average of pixels deter-
mined in the corresponding unspecific band shown in 
Figure S1B.
Quantitative Real-Time PCR (qRT-PCR) of nrdA, 
nrdJ and nrdD genes
Intracellular expression of P. aeruginosa nrd genes was 
assessed by doing a qRT-PCR with samples taken after 
3 and 24 h of PAO1, PA14, PAET1, PAET2, and 
PAET4 intracellular persistence inside A549 mono-
layers. The infection conditions were the same as 
those used for the western blot analysis. At each time 
point, infected monolayers were washed with 1X PBS 
and lysed with saponin buffer. Samples were treated 
with RNAlater (ThermoFisher Scientific), to preserve 
the integrity of the RNA. RNA was isolated using the 
GeneJET RNA Purification kit (ThermoFisher 
Scientific) following the manufacturer’s instructions. 
RNAs were treated with DNase I (Ambion) to ensure 
that samples were clear of DNA traces.
Total RNA samples were adjusted to 1 μg and retro-
transcribed using the Maxima reverse transcriptase 
(ThermoFisher Scientific) and random hexamer pri-
mers (ThermoFisher Scientific).
qRT-PCR of nrdA, nrdD, nrdJ genes, in the different 
infectious conditions and time points was done with 1 μl 
of cDNA per reaction, using PowerUP Sybr Green Master 
Mix (ThermoFisher Scientific) and specific primers of 
P. aeruginosa’s nrd genes [18]. The glyceraldehyde 
3-phosphate gene (gapA) was used as an internal control. 
qRT-PCR was performed in a StepOnePlus real-time PCR 
system (Applied Biosystems), and the 2−ΔΔCT method was 
used to analyze the data and determine each intracellular 
gene induction between time points.
Fluorescence microscopy and cellular hypoxia 
determination
A549, 16HBE14o-, and CFBE41o- cells were indepen-
dently seeded into a Millicell® EZ SLIDE with eight 
wells (Merck Millipore) and left until confluence. For 
this experiment, phenol red-free DMEM/F12 
(ThermoFisher Scientific) was used to avoid autofluor-
escence of the medium when visualized under 
a microscope. Monolayers were infected with the dif-
ferent P. aeruginosa strains for 3 h at a MOI = 100. 
After infection, the cells were washed 3 times with 
warm 1X PBS and then incubated with a gentamicin 
solution supplemented with the hypoxia probe dye 
(Organogenix) for 30 min (~3 h time point postinfec-
tion) and 21 h (24 h time point postinfection) indepen-
dently. This probe allows the detection of environments 
with low oxygen levels since its phosphorescence is 
quenched by oxygen; therefore, its signal increases in 
response to a low oxygen content (red fluorescence). 
The hypoxia probe was used following the manufac-
turer’s instructions (Organogenix).
Stained monolayers were visualized under a Nikon 
inverted fluorescence microscope ECLIPSE Ti-S/L100 
(Nikon) coupled with a DS-Qi2 Nikon camera (Nikon) 
to detect changes in the intracellular oxygen content 
depending on the P. aeruginosa strain and/or lung cell 
type. Analysis of the images obtained was performed 
using ImageJ FIJI software.
A549, 16HBE14o- and CFBE41o- viability after 
24 h of P. aeruginosa intracellular persistence
Lung cell viability was assessed in a 96-well microtiter 
plate after 3 h of infection with the P. aeruginosa strains 
PAO1, PA14, PAET1, PAET2, and PAET4 at 
a MOI = 100 followed by 21 h of incubation with 
gentamicin solution by using the PrestoBlueTM Cell 
Viability Reagent (Invitrogen). Cells incubated with 
dimethyl sulfoxide (DMSO) for 21 h were used as 
a positive control for toxicity. PrestoBlueTM is quickly 
reduced by metabolically active cells; hence, higher 
absorbance values correlate to greater metabolic activ-
ity. The reagent was used according the manufacturer’s 
instructions. Briefly, at the previously mentioned time 
point, 10 µl of PrestoBlueTM was added to each well, 
and the plate was subsequently incubated for 1 h at 
37ºC. After incubation, absorbance was read at λ = 570 
using a microplate reader (Infinite M200 Microplate 
reader, Tecan). The given values were corrected by 




The adhesion vs invasion values of P. aeruginosa were 
compared using an unpaired t-test. Otherwise, differ-
ences in bacterial intracellular CFUs/monolayer over 
time, monolayer toxicity among the different 
Pseudomonas infections and differences between pixel 
intensities were analyzed by using one-way ANOVA 
with Dunnett’s multiple comparison test with 
GraphPad Prism 8.0 software.
Results
Specialization of CF clinical isolates of 
P. aeruginosa to interact with alveolar and 
bronchial epithelial cell monolayers
The interactions of P. aeruginosa strains with the different 
lung epithelial cells were examined. Two laboratory refer-
ence P. aeruginosa strains (PAO1 and PA14) along with 
three different clinical isolates from CF patients (PAET1, 
PAET2, and PAET4) were used in this study. After infec-
tion of A549, 16HBE14o- and CFBE41o- monolayers with 
the different P. aeruginosa strains for 3 h at a multiplicity of 
infection (MOI) = 100, the adhesion patterns of the PAO1, 
PA14, PAET1, PAET2, and PAET4 strains showed no 
significant changes (p > 0.05) when adhering to the same 
epithelial cell type (Figure 1 and Table S1). Major differ-
ences were observed when comparing the adhesion of the 
different Pseudomonas strains to A549 monolayers with 
their adhesion to 16HBE14o- or to CFBE41o- monolayers, 
as adhesion of some P. aeruginosa strains to A549 cells 
were detected significantly higher (Table S1). Specifically, 
and according to the statistical analysis done (Table S1), the 
reference PAO1 and PA14 strains exhibited higher adhe-
sion to A549 monolayers than to 16HBE14o- and to 
CFBE41o- monolayers (p < 0.01). Similarly, the clinical 
isolates PAET2 and PAET4 showed greater adhesion to 
A549 monolayers than to CFBE41o- monolayers (p < 0.05), 
while PAET1 adhesion to A549 monolayers was also 
detected higher than to 16HBE14o- monolayers (p < 0.05; 
Figure 1 and Table S1).
Otherwise, significant differences in cell invasion were 
observed among the strains used depending on the type of 
lung epithelial cell that they were infecting. Remarkably, 
the clinical isolates showed an ~1.5–2 log10 higher capa-
city to invade 16HBE14o- and CF-related CFBE41o- cells 
than that of the P. aeruginosa reference PAO1 and PA14 
strains (Figure 1), with invasion rates of ~20-50% and 
intracellular CFUs of ~1x104-1x105 CFU/monolayer. 
Conversely, the reference PAO1 and PA14 strains had 
invasion rate percentages of ~0.39–3.78% for 
16HBE14o- and CFBE41o- cells (Table 1). In contrast, 
in A549 cells, the intracellular Pseudomonas CFUs were 
~106 CFU/monolayer among the different strains except 
for PA14 (Figure 1), and the highest invasion rate was 
calculated for the clinical isolate PAET1 (21.76%). PAO1 
and the CF isolates PAET2 and PAET4 had similar inva-
sion rates, ~4.0–6.96% (Table 1). As expected, the cyto-
toxic P. aeruginosa PA14 strain had the lowest invasion 
capacity, with invasion rates of 0.39–0.79% among the 
three epithelial monolayers.
From these experiments, we could conclude that while 
similar adhesion properties were observed among the 
different Pseudomonas strains, the clinical CF isolates 
demonstrated a slightly increased invasion ability toward 
bronchial 16HBE14o- and CF- CFBE41o- cells than in the 
A549 cells. Otherwise, the reference PAO1 and PA14 
strains reflected reduced capacity to invade both bron-
chial cells than invade A549 monolayers.
Higher persistence of intracellular CF-isolated 
Pseudomonas in 16HBE14o- and CFBE41o- cells
Once cellular invasion was confirmed, we next analyzed 
the intracellular persistence among the different 
Pseudomonas strains within the three types of lung 
epithelial cells. This experiment was performed by initi-
ally infecting epithelial cells at a MOI = 1 for 3 h instead 
of a MOI = 100 to avoid rapid saturation of the cell 
monolayers. The intracellular P. aeruginosa CFUs were 
counted after 1.5 h, 3 h, 4.5 h, 6 h and 21 h of incuba-
tion with gentamicin (Gm) treatment (see Figure 2). 
The survival slope of each strain was also calculated to 
confirm the respective intracellular tendency inside the 
different alveolar and bronchial cells, as well as the 
percentage of intracellular CFU/monolayer at the 21 h 
time point compared to 1.5 h incubation with Gm 
(Table S2).
The results clearly showed the high persistence of 
the P. aeruginosa CF isolates PAET1, PAET2, and 
PAET4 inside the bronchial 16HBE14o- and CF- 
affected CFBE41o- cells, with intracellular CFUs main-
tained at ~1x107 CFUs/monolayer over the course of 
the experiment (Figure 2). PAET1 strain reflected 
a 108.39% and 87.51% of the increase in CFU/mono-
layer after 24 h of intracellular infection of 16HBE14o- 
and CFBE41o-, respectively, while that increase was 
calculated of 37.07% and 101% in the PAET4 during 
infection of the same cells (Table S2). Only PAET2 
showed a significantly decreased persistence at the 
21 h time point, with CFUs of ~1x104 per monolayer 
of 16HBE14o- and CFBE41o- bronchial cells (p 
< 0.001), corresponding to a 0.03% and 0.21% of survi-
val with slopes calculated significantly non-zero (Table 
S2). In these two cell lines, the P. aeruginosa PAO1 and 
PA14 reference strains were able to persist 
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intracellularly, although at lower CFUs per monolayer. 
Within 16HBE14o- cells, the CFU of PAO1 remained 
~1x105 over the initial 6 h with Gm treatment, but 
a significant decrease (p < 0.01) was detected at the 
21 h time point. A similar persistence pattern was 
observed for this reference strain inside cystic fibrosis 
CFBE41o- cells, although fewer CFUs were counted 
intracellularly: ~1x103 -~1x504 CFU/monolayer 
(Figure 2). The survival percentages of the PAO1 strain 
at 24 h time point were calculated of 7.01% and 21.31% 
inside of 16HBE14o- and CFBE41o- cells, respectively 
(Table S2). Otherwise, the CFUs of PA14 were ~1x104 
CFU/monolayer, with a gradual decrease to ~1x103 
CFU/monolayer at the final time point in both bron-
chial cell lines (Figure 2). In this reference strain, the 
survival percentage in CFU/monolayer after 24 h of 
infection (21 h of Gm treatment) was calculated of 
2.63% and 5.69% inside 16HBE14o- and CFBE41o- 
monolayers (Table S2).
On the other hand, within A549 cells, the different 
P. aeruginosa strains showed a similar intracellular 
persistence during the initial 3 h of intracellular infec-
tion, and significant differences were detected from that 
time point on (Figure 2). The intracellular CFUs/ 
monolayer were ~1x103- ~1x105 in all strains over the 
course of the experiment except for PAET1, which 
showed a significant CFU increase at the 6 h time 
point (p < 0.001) that was maintained until the 21 h 
time point (Figure 2). For this clinical isolate, the sur-
vival percentage was calculated of 1030% after 24 h of 
intracellular persistence inside A549 cells with 
a positive slope determined significantly non-zero 
(Table S2). The PAET4 strains also reflected 
a significant increase of CFU/monolayer at this final 
time point calculated of the 719.37% (Figure 2 and 
Table S2). In these alveolar cells, the clinical isolate 
PAET2 behaved similar than the reference PAO1 and 
PA14 strains, with survivals calculated for the three 
P. aeruginosa strains between the 9.98% and 29.29% 
(Table S2).
In summary, these results demonstrate that while the 
reference strains showed similar intracellular persis-
tence patterns among the three lung epithelial cell 
lines, the clinical isolates of P. aeruginosa had an 
Figure 1. Interactions of P. aeruginosa’s with alveolar and bron-
chial lung epithelial cells. The adhesion and invasion values of 
P. aeruginosa PAO1, PA14, PAET1, PAET2 and PAET4 to A549, 
16HBE14o- and CFBE41o- cells. The different plots show the 
log10 CFUs of each strain counted as adhered (adhered + 
invaded) and as only intracellularly invaded per monolayer of 
the different epithelial cells. Three independent experiments 
are plotted in each graph, and the error bars indicate the 
standard error of the mean from representative triplicate 
experiments. Statistical significance between the adhered and 
the invaded log10 of each strain CFU/monolayer point is indi-
cated with an asterisk (*p < 0.05; ** p < 0.01; *** p < 0.001).
Table 1. Percentage (mean±SD) values of the P. aeruginosa 
invasion rate per lung cell after 3 h of infection at a MOI = 100.
A549 16HBE14o− CFBE41o−
PAO1 5.50 (±3.15) % 3.78 (±1.05) % 3.24 (±1.01) %
PA14 0.77 (±0.18) % 0.39 (±0.08) % 0.79 (±0.18) %
PAET1 21.76 (±5.55) % 19.31 (±2.09) % 50.05 (±10.51) %
PAET2 6.96 (±1.91) % 37.81 (±3.98) % 18.07 (±3.06) %
PAET4 4.04 (±0.47) % 40.88 (±5.47) % 31.33 (±6.28) %
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increased tendency to invade and persist inside the 
different bronchial cells. In some cases, intracellular 
replication of some Pseudomonas strains could also be 
detected in addition to just persistence, as it was the 
case of PAET1 and PAET4. Nevertheless, when 
cytotoxicity was assessed to ensure that the CFU 
counted inside the epithelial cells after 21 h of Gm 
treatment come from viable cells, no significant 
changes (p > 0.05) were detected between the 21 h Gm- 
treated infected monolayers and untreated cells 
(Figure 3). Although some monolayers contained apop-
totic cells with clear nuclear condensation, no major 
destruction was observed, and the three different lung 
cells retained their confluency (Figure S2). Only treat-
ment with DMSO promoted a loss of viability and 
cellular destruction (Figure 3 and Figure S2).
Differential oxygen consumption among the lung 
cells depends on the type of infectious 
P. aeruginosa strain
Oxygen is a critical element for aerobic metabolism and 
biofilm formation [19]. In contrast to eukaryotic organ-
isms, some prokaryotes can modulate their metabolism 
and live under anaerobic conditions [20]. In tissues, 
hypoxia is a symbol of damage, inflammation, and infec-
tion [10]. Therefore, the oxygen consumption promoted 
by infection of the different lung epithelial monolayers 
with the Pseudomonas strains was examined. For the 
examination of oxygen consumption, the levels of intra-
cellular oxygen after 3 and 24 h of monolayer infection 
were analyzed using a hypoxia probe (Figure 4). 
Figure 2. Differential pattern of intracellular persistence among 
the Pseudomonas strains depending on the lung epithelial cell 
type. The figure shows the log10 CFUs/monolayers of PAO1, 
PA14, PAET1, PAET2, and PAET4 after 1.5, 3, 4.5, 6 and 21 h 
incubation with gentamicin 200 µg/mL after 3 h of infection at 
a MOI = 1. The standard error of the mean from representative 
triplicate experiments is indicated with the error bars. 
Significant differences between the CFUs counted per mono-
layer between time points for each strain and cell line are 
indicated with asterisks (*p < 0.05; ** p < 0.01; *** p < 0.001; 
**** p < 0.0001).
Figure 3. Intracellular persistence of the P. aeruginosa reference 
and clinical strains does not affect lung cell viability. A549, 
16HBE14o- and CFBE41o- toxicity after 24 h of intracellular 
persistence of PAO1, PA14, PAET1, PAET2, and PAET4. The 
plot shows the normalized values of the absorbance measured 
at A570 to the absorbance of the reference A600, as recom-
mended by the PrestoBlueTM manufacturer. Higher absorbance 
values indicate greater metabolic activity and therefore viabi-
lity. Data from three independent experiments are shown, and 
the error bars indicate the standard error of the mean of 
representative triplicate experiments. Untreated monolayers 
were used as controls for viability, and DMSO-treated cells 
were used as controls for toxicity. A representative picture of 
the PrestoblueTM-treated cells is included in the figure in which 
the gradient from pink (viable cells) to dark blue (toxic cells) is 
related to the level of cellular toxicity.
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Uninfected A549, 16HBE14o- and CFBE41o- monolayers 
were included as controls.
Red intensity quantification revealed that all of the 
uninfected lung epithelial monolayers did not increase 
the respective hypoxic state between 3 and 24 h (p > 0.05, 
Figure 4). The red intensity quantified in the different 
A549, 16HBE14o- and CFBE41o- infected monolayers 
was normalized with that detected in the respective unin-
fected-control cell. The difference in red intensity 
between 3 and 24 h of each cell infection was subse-
quently calculated as relative to oxygen consumption. 
An increase in cellular anaerobiosis was detected in all 
infected cells, independently of the P. aeruginosa strain, 
after 3 and 24 h (Figure 4a,b). This increase was calcu-
lated to be between 5.2% and 39.6% (Figure 4a). 
Generally, the increase in red intensity promoted by 
a 3 h infection of the CF-derived CFBE41o- monolayers 
was detected to be higher than that observed in the other 
lung epithelial cells regardless of the Pseudomonas infec-
tion type (Figure 4a,b). Significantly, a higher increase in 
anaerobiosis (red intensity) was detected after 3 h in 
CFBE41o- monolayers infected with PAO1, PAET1, 
and PAET2 compared to that caused by infection of the 
other cells (p < 0.05). This increase was calculated to be 
between ~1.5- and ~2.30-fold compared to that caused by 
the other infection types (Figure 4b). Among the intra-
cellular infections incubated for 24 h, the anaerobic state 
promoted by PAO1 and PAET1 in CFBE41o- cells was 
significantly increased (p < 0.05) compared to that caused 
by PAO1 and PAET1 in A549 or 16HBE14o- cells. These 
increases were calculated to be ~1.37- and 1.53-fold 
higher for PAO1 infection of CFBE41o- compared to 
PAO1 infection of A549 and 16HBE14o-, respectively, 
and ~1.73- and 2.74-fold higher for the same compar-
isons but with PAET1 (Figure 4b). Furthermore, PA14 
infection of both 16HBE14o- and CFBE41o- cells also led 
to higher oxygen consumption than that after infection of 
A549 cells (Figure 4a,b).
This experiment confirmed differential oxygen con-
sumption intracellularly between the different A549, 
16HBE14o-, and CFBE41o- infections with the refer-
ence and clinical isolates of P. aeruginosa.
The intracellular environment modulates 
Pseudomonas RNR expression over time
The P. aeruginosa reference strains and the clinical 
isolates promoted different oxygen consumption and 
cellular hypoxia levels among the three lung epithelial 
cells. Furthermore, the different P. aeruginosa strains 
were able to persist within the A549, 16HBE14o-, and 
CFBE41o- cells, thus indicating their capacity for DNA 
replication in this oxygen-changing environment. As 
ribonucleotide reductase (RNR) plays a key role in the 
synthesis of the dNTPs required for DNA replication, 
we next studied its expression after 3 and 24 h of 
monolayer infection.
Since the P. aeruginosa strains used in this work 
came from different backgrounds, the protein expres-
sion pattern of each strain was analyzed at the chosen 
time points to evaluate RNR expression. Thus, the 
protein expression profiles of PAO1, PA14, PAET1, 
PAET2, and PAET4 were examined after 3 and 24 h 
of growth (Figure 5). Interestingly, while all the strains 
showed a similar protein expression pattern after 3 h of 
growth (exponential phase), the protein expression pat-
terns completely changed at the 24 h time point. After 
24 h of bacterial growth, the picture was different, and 
only the clinical isolates PAET1 and PAET4 had similar 
protein band profiles to those detected at the 3 h time 
point. PAO1, PA14, and PAET2 showed completely 
different protein expression patterns between the two 
time points (Figure 5).
Extracellular detection of the ribonucleotide reductase 
protein (Nrd) showed a clear common pattern among the 
different P. aeruginosa strains, in which NrdA (class Ia 
RNR) and NrdJa (class II RNR; referred to NrdJ from this 
point onwards) dominated extracellular expression. 
However, NrdJ was detected at lower levels than NrdA 
protein. As expected, NrdD protein (class III RNR) was 
not detected under aerobic conditions in any of the 
P. aeruginosa strains (Figure 6a). Western blot analysis 
revealed that intracellular NrdA and NrdJ expression chan-
ged among the P. aeruginosa strains, although a common 
pattern was found among the different infected lung epithe-
lial monolayers. Furthermore, for these two RNR proteins, 
the expression profile changed between 3 and 24 h, with 
a clear induction of NrdJ, while NrdA tended to decrease 
during intracellular persistence within lung epithelial cells 
(Figure 6a,b). Clearly, the PAO1 and PAET2 strains showed 
higher NrdA expression after 3 h of intracellular infection 
than that of PA14, PAET1, and PAET4, independently of 
the type of infected lung epithelial cell. These two groups of 
Pseudomonas had a similar intracellular pattern of NrdA 
expression at the 3 h time point. Protein band quantifica-
tion and average pixel calculations determined that NrdA 
expression in the PAO1 was ~1.98–11.01-fold higher than 
that detected in PA14, PAET1, and PAET4 in infected cells 
of the three epithelial lung cell lines. On the other hand, 
NrdA induction in the PAET2 strain, compared to the 
other three P. aeruginosa strains after 3 h of infection of 
A549, 16HBE14o-, and CFBE41o- was calculated of ~3.-
14–42.36-fold (Figure 6a,b and Supplementary Table S3). 
However, after 24 h of intracellular persistence, the different 
P. aeruginosa strains had similar NrdA expression within 
alveolar and bronchial cells, revealing similar protein 
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Figure 4. Oxygen consumption of A549, 16HBE14o- and CFBE41o- P. aeruginosa-infected monolayers. A) Fluorescence microscope 
images showing the red fluorescence emission of the hypoxia probe dye after 3 and 24 h of initial infection of the PAO1, PA14, 
PAET1, PAET2 and PAET4 strains. Uninfected A549, 16HBE14o- and CFBE41o- were also included as controls. The red-intensity signal 
relates to cellular hypoxia. The percentage of red intensity increases from 3 h to 24 h of intracellular persistence per infection and 
lung epithelial cell type and is included in the figure. The percentages were calculated with ImageJ software using the pixel intensity 
averages from ten different images of each infectious condition and time-point. B) Graphs showing the pixel intensity averages and 
the respective standard error of the mean of each P. aeruginosa intracellular infection of A549, 16HBE14o- and CFBE41o- cells 
incubated for 3 and 24 h. Significance differences among lung cell infections with the same P. aeruginosa strains are denoted with 
asterisks (*) p > 0.05.
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expression patterns (Figure 6a). In that sense, the majority 
of P. aeruginosa strains suffered a reduction of ~1.05- to 
~27.66-fold in NrdA expression during 24 h of intracellular 
persistence (Figure 6b). Significantly, protein band quanti-
fication determined that NrdJ expression by the different 
P. aeruginosa strains increased from ~1.43- to 13.33-fold 
after 24 h of intracellular persistence. In the P. aeruginosa 
PAO1 reference strains, the expression of NrdJ increased by 
~1.43-, 4.01-, and 2.29-fold after 24 h of intracellular infec-
tion of A549, 16HBE14o-, and CFBE41o- cells, respectively. 
Otherwise, induction of NrdJ expression between the two 
time points was significant in the other reference strain, 
P. aeruginosa PA14, with protein inductions of ~13.33-, 
~6.00- and ~8.47-fold for the same cell infections. Among 
the P. aeruginosa clinical isolates, the PAET1 and PAET4 
strains showed higher intracellular induction of NrdJ 
expression than that in PAET2, although increased levels 
of the protein were also detected after 24 h in PAET2 
intracellular infection (Figure 6a,b). Specifically, in the 
PAET1 strain, NrdJ expression increased by ~11.99-, 
~3.29- and ~4.88-fold after 24 h of intracellular persistence 
in A549, 16HBE14o-, and CFBE41o- cells, respectively. 
PAET2 revealed a class II RNR protein induction of 
~1.91-, ~1.71- and ~5.02-fold for the same cell infections 
and intracellular persistence time, while in the clinical 
PAET4, NrdJ induction was calculated to be ~6.17-, 
~5.83- and ~2.90-fold higher after 24 h of intracellular 
persistence within the different lung epithelial monolayers.
On the other hand, no major differences were 
detected in the expression of the NrdD protein between 
the different P. aeruginosa strains. The expression of 
this RNR protein was higher after 3 h of infection than 
after 24 h, and only PAET4 demonstrated a ~ 2.13-fold 
induction of NrdD expression after 24 h of intracellular 
persistence in 16HBE14o- cells (Figure 6a,b). 
Interestingly, the induction in NrdD expression in 
PAET4 coincided with the infection condition that 
caused the highest increase in cellular hypoxia 
(~40.2%) after 24 h of intracellular persistence, as 
shown in Figure 4.
These results indicate an important role of class II 
RNR in providing the dNTPs necessary for DNA 
homeostasis during intracellular P. aeruginosa infection 
of lung epithelial cells, for which different times may be 
required, depending on the P. aeruginosa strain, to shift 
from the extracellularly expressed class Ia RNR to the 
class II RNR.
Intracellular modulation of the nrd genes 
between the reference and clinical P. aeruginosa 
strains leads to their essential role during the 
intracellular survival of the strain
To confirm the results of RNR’s intracellular protein 
expression in the different reference strains and clinical 
isolates of P. aeruginosa, qRT-PCR of nrdA, nrdD and 
nrdJ genes were performed after 3 and 24 h of persis-
tence within the A549 cells. Since, the tendency of 
RNR’s expression in the strains was similar between 
the different lung epithelial cells (Figure 6), this experi-
ment was performed only in the A549 cells. Results 
indicated a similar expression pattern between the 
reference PAO1 and PA14 strains together with the 
PAET1 clinical isolate (Figure 7a). In these three 
strains, the nrdD and nrdJ genes reflected a clear intra-
cellular induction, whereas nrdA expression was 
repressed. Inductions for the nrdD gene after 24 h of 
Figure 5. Shifting protein expression pattern among the refer-
ence and CF isolates of P. aeruginosa. The figure shows the 
picture of two SDS-PAGE gels with the protein extracts of the 
PAO1 and PA14 reference strains together with the PAET1, 
PAET2 and PAET4 CF-clinical isolates after 3 and 24 h of 
planktonic growth. While all P. aeruginosa strains shared similar 
protein pattern after 3 h of growth, it completely changed after 
24 h, with a completely different protein expression profile 
between strains independently their background.
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intracellular infection were calculated ~32 fold in the 
PAO1, ~1.8 fold in the PA14 reference strain and ~4.2 
in the clinical PAET1 isolate. Otherwise, nrdJ expres-
sion showed ~5–7 fold induction in these three 
P. aeruginosa strains. On the other side, the PAET2 
and PAET4 clinical isolates reflected a different and 
unique, nrd gene expression pattern. While the clinical 
PAET2 strain only showed intracellular induction for 
Figure 6. Different lung intracellular backgrounds promote differential RNR expression among P. aeruginosa strains. A) Intracellular 
NrdA, NrdJ and NrdD protein expression in P. aeruginosa PAO1-, PA14-, PAET1-, PAET2- and PAET4-infected A549, 16HBE14o- and 
CFBE41o- cells after 3 and 24 h are shown in the figure. The levels of extracellular P. aeruginosa NrdA, NrdJ and NrdD from the same 
strains grown in the extracellular phase (media) while infecting are also included. Specific NrdA, NrdD and NrdJ protein bands were 
selected according their molecular weight as given by antibodies binding to purified NrdA, NrdD and NrdJ proteins from our 
laboratory stock (Figure S1A). Unspecific bands of each independent Nrd protein immunoblot were used as loading controls, and the 
detection of purified NrdA (~107.1 kDa), NrdJ (~82.7 kDa) and NrdD (~76.1 kDa) proteins with polyclonal antibodies was used as the 
Nrd protein band detection control (Figure S1B). B) The different plots show the average of the number of pixels calculated in the 
volume of NrdA, NrdJ and NrdD protein bands using ImageQuantTM LAS4000 software. A higher pixel intensity in the protein band 
volume indicates higher expression of the target protein under a specific infection condition. Each plot compares the Nrd protein 
bands detected at 3 and at 24 h of intracellular persistence inside of A549, 16HBE14o- and CFBE41o- monolayers and includes the 
fold induction of each protein at the 24 h time-point. Protein induction was calculated using the average of the pixels determined 
from each protein band at both time-points, previously normalized by the average of the pixels determined in the respective 
unspecific band shown in (Figure S1B).
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the nrdJ gene, which was calculated ~6 fold increased at 
24 h compared to 3 h infection, the PAET4 isolate 
induced the three nrdA, nrdD and nrdJ genes during 
the 24 h of persistence. 24 h expression of nrdA gene 
was calculated >4 fold compared to 3 h infection, while 
nrdD and nrdJ inductions were calculated ~3 and ~6 
fold, respectively, in the PAET4 during the intracellular 
infection (Figure 7a).
To finally demonstrate the importance of classes II 
and III RNR during the intracellular survival of 
P. aeruginosa, we evaluated the ability to persist off 
the ΔnrdJ and ΔnrdD isogenic mutants inside the 
A549 cells, compared to their PAO1 WT strains in 
the same conditions and time points as shown in 
Figure 2. The complemented strains for the PAO1 
ΔnrdJ and PAO1 ΔnrdD were constructed and included 
in the experiment. After 24 h of intracellular persis-
tence, both PAO1 ΔnrdJ and PAO1 ΔnrdD mutants 
reflected less intracellular survival than that observed 
by the PAO1 WT strain, with the percentage of intra-
cellular survival after 24 h calculated ~20.45% for the 
nrdD mutant and ~10.52% for the ΔnrdJ strain (Figure 
7b). When the respective mutations were complemen-
ted, intracellular survival increased to ~46.26% and 
~58.53% for PAO1 ΔnrdD and PAO1 ΔnrdJ 
respectively. On the other hand, the PAO1 strains 
showed similar persistence than that shown in Figure 
2, with final intracellular survival calculated ~33.40% 
(Figure 7b).
Overall, these results confirm the critical role of class 
II RNR during the intracellular survival of 
P. aeruginosa strains.
Discussion
In this study, we focused on the analysis and under-
standing of the chronicity of lung infections promoted 
by the intracellular persistence of P. aeruginosa. Using 
two P. aeruginosa reference strains and three different 
clinical isolates, we confirmed differential infectious 
behaviors depending on the P. aeruginosa background, 
indicating a directed specialization of the clinical iso-
lates to infect a particular type of lung epithelial cell. 
Evaluations of the intracellular oxygen levels in basal 
uninfected alveolar (A549) and bronchial (16HBE14o- 
and CFBE41o-) cells as well their specific and indepen-
dent changes during infection with the different 
Pseudomonas strains were also analyzed. Significantly, 
our investigations revealed that expression of class II 
RNR is highly induced during P. aeruginosa intracellu-
lar infection and is thus the major dNTP supplier dur-
ing intracellular persistence of this pathogen.
Intracellular invasion is an advantageous mechanism 
used by P. aeruginosa, among many other pathogens, to 
evade the host immune system and antimicrobial ther-
apy, which consequently promotes infection persistence 
and recurrence [21]. P. aeruginosa has been shown to 
invade nonphagocytic cells, such as endothelial or 
epithelial cells. Successful invasion is mediated by 
cytoskeletal rearrangements of eukaryotic host cells by 
the modulation of host actin and microtubule dynamics 
[22,23]. At that level, P. aeruginosa expresses different 
virulence factors to inject different toxins as well as to 
facilitate cellular uptake [7]. Adhesion to and subse-
quent invasion of the different A549, 16HBE14o-, and 
CFBE41o- epithelial cells were detected among the dif-
ferent P. aeruginosa strains regardless of the back-
ground of the strains. After invasion, the reference 
P. aeruginosa PAO1 and PA14 strains in addition to 
the different PAET1, PAET2 and PAET4 CF isolates 
showed the capacity to persist intracellularly, with 
detection of bacterial growth occurring with the 
PAET1 and PAET4 P. aeruginosa clinical strains within 
the A549 cells (Figures 1 and 2). However, the invasion 
rates and the levels of intracellular persistence and 
replication were found to be cell- and strain- 
dependent. The invasion capacity of the P. aeruginosa 
strains within host cells in vitro notwithstanding the 
Figure 7. Intracellular expression of the P. aeruginosa’s nrd 
genes and their importance during the persistence of the 
bacterium inside the A549 cells. A) Fold-change induction of 
nrdA, nrdJ and nrdD gene expression in PAO1-, PA14-, PAET1-, 
PAET2- and PAET4-infected A549 after 24 h of intracellular 
infection compared to 3 h. The nrd gene induction was calcu-
lated relative to the endogenous control gapA and using the 
2−ΔΔCT method. B) Percentages of intracellular survival for the 
PAO1 WT, PAO1 ΔnrdJ, PAO1 ΔnrdD and the respective PAO1 
ΔnrdJ+pETS218 and PAO1 ΔnrdD+pETS197 complemented 
strains after 21 h of Gm treatment. Cb 300 μg/mL was included 
during the experiment in the conditions with the complemen-
ted strains to ensure plasmid maintenance.
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P. aeruginosa phenotype have been broadly observed 
[7,17,21,23]. It should be noted that there is heteroge-
neous genotypic clonality among P. aeruginosa infec-
tions as well as different protein expression profiles 
(including important virulence factors) that depend 
on the P. aeruginosa background [4,24]. In this sense, 
large portions of DNA in the genomes of these 
P. aeruginosa clinical strains are missing in the refer-
ence and well-studied PAO1 strain [1,2,9]. Our study 
revealed a shifting protein expression pattern across the 
different reference and clinical P. aeruginosa strains, 
which was found to change over time. Thus, while 
a similar protein profile was detected after 3 h of 
growth, it completely changed by 24 h, with no correla-
tion with the original bacterial background (Figure 5). 
Significantly, adapted CF-Pseudomonas undergo 
pathoadaptative mutations, genomic rearrangements 
and deletions that are evolutionarily selected to be 
beneficial to survive in the CF lung environment. 
These adaptive mutations and genomic rearrangements 
evolve differently depending on the patient [4,24]. In 
agreement with these observations, our results showed 
the clear efficiency of the CF isolates to persist and 
replicate intracellularly in bronchial 16HBE14o- cells 
and their CF-derived CFBE41o- cells.
Since a similar behavior among the different 
P. aeruginosa strains was detected within adenocarci-
nomic A549 cells, it is possible that the CF isolates 
PAET1, PAET2, and PAET4 encode similar mutations 
and have other similarities in their genome that favor 
their persistence within the bronchial epithelium that 
could be lacking in the PAO1 or PA14 genomes. 
Therefore, the possible mutations or genomic rearran-
gements occurring in previous infections may have 
allowed the clinical isolates to develop the most suc-
cessful invasion capacity. Furthermore, the CFTR pro-
tein has been postulated to be important for 
P. aeruginosa internalization inside lung epithelial 
cells [25], which supports the idea that the clinical CF 
isolates PAET1, PAET2, and PAET4 may have under-
gone directed adaptation to allow them to colonize 
CFBE41o- cells, as we have detected in our work. 
Inside the cell, P. aeruginosa can persist and replicate 
intracellularly, as detected in our study as well as in 
other cellular models [7,17,25]. Bacterial persistence 
within host cells can constitute a latent reservoir that 
is helped by the poor intracellular penetration of some 
antibiotics and can lead to the selection of antibacterial 
resistant mutants and contribute to disease harshness 
and chronicity [7,21].
Studies have indicated that P. aeruginosa grows in 
cystic fibrosis lungs via aerobic respiration, yet the 
mucus plugs present in the CF airways are majorly 
anoxic microenvironments [26]. Furthermore, cellular 
hypoxia is usually associated with infection, injured 
tissue, or inflammation and plays an important role in 
the host immune response [10]. Specifically, for 
P. aeruginosa infections, hypoxia has been shown to 
modulate infection in epithelial cells [27]. In this 
work, different basal levels of cellular oxygen were 
detected in pulmonary epithelial cells, with a higher 
state of hypoxia detected in CFBE41o- cells than in 
16HBE14o- or A549 cells. Additionally, the CF isolates 
mediated faster oxygen depletion when infecting 
CFBE41o- monolayers (Figure 4). ΔF508 CFTR cells 
have altered lipid homeostasis, which can induce cellu-
lar death and apoptosis [28]. Furthermore, CFBE41o- 
cells express lower levels of heme oxygenase-1 (HO-1), 
a stress-inducible protein with anti-inflammatory and 
antioxidant properties that are induced by signals 
mediated through LPS binding to Toll-like receptor 4 
(TLR4). Nevertheless, CFBE14o- cells have an impaired 
expression of TLR4 at the cellular surface. The lack of 
HO-1 is known to promote iron accumulation inside 
CFBE41o- cells, which leads to cellular hypoxia with 
abnormal activity of hypoxia-inducible factor 1α (HIF- 
1α) [29]. The absence of HO-1 has also been linked to 
continuous inflammation and cellular damage state in 
mice [30], which may explain the higher basal toxicity 
detected in CFBE41o- monolayers (Figure 3). It is pos-
sible that this increased toxicity may influence the 
intracellular persistence of the bacterium. However, in 
addition to the basal oxygenic state of the cells, 
a common trait among the different infectious condi-
tions was the differential oxygen consumption during 
the intracellular persistence of the different 
P. aeruginosa strains within the A549, 16HBE14o-, 
and CFBE41o- monolayers, which is in agreement 
with other studies, indicating that pathogen coloniza-
tion of the lung epithelium exacerbates tissue hypoxia 
[31] by increasing their own metabolism [18].
Intracellular lifestyles, as all types of lifestyle, require 
a continuous dNTP supply to survive, and the RNR is the 
unique enzyme capable of providing de novo dNTPs [6]. 
In this paper, we found that the intracellular lifestyle 
drives P. aeruginosa to express class II RNR (NrdJ) as 
the dNTP supplier. High NrdJ induction was detected in 
all strains regardless of the type of epithelial cell they were 
infecting. However, at earlier infection times, higher NrdJ 
protein expression was detected during Pseudomonas 
intracellular infection of bronchial cells than A549 cells 
(Figure 6). As an indispensable requisite, class II RNR 
depends on vitamin B12 or 5ʹ-deoxyadenosylcobalamin 
(AdoCbl) to act as an external cofactor to perform its 
enzymatic activity. Vitamin B12 was included in the for-
mulation of the cell culture media used in this study. 
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People with CF supplement their diet with vitamin B12 
due to their malabsorption of fat- and water-soluble vita-
mins as a consequence of pancreatic enzymes and bile salt 
deficiencies, which increase the levels of this vitamin in 
serum [32]. We have recently demonstrated higher levels 
of intracellular vitamin B12 in the CF-isolate PAET1 
compared to those in the reference PAO1 strain [33]. 
Previous studies detected the induction of class III RNR 
and class II RNR during P. aeruginosa infection of 
Drosophila melanogaster [5] and of Danio rerio [14], in 
the present study, induction of nrdD expression was 
detected at the gene expression level but not at the protein 
level. NrdD was only moderately overexpressed in the CF- 
isolate PAET4 after 24 h of intracellular persistence of 
16HBE14o- cells, which is the infectious condition that 
promoted higher induction of hypoxia. Class III RNR 
expression in P. aeruginosa has been shown to be 
increased under anaerobic conditions with the subse-
quent repression of class I and II RNRs [14]. Although 
hypoxia was confirmed to occur in the different infec-
tions, possible trace oxygen present in different intracel-
lular compartments may prevent the activity of the 
anaerobic class III RNR. The oxidative stress present in 
the cellular compartments promoted by infections, as has 
been observed in CF-affected lungs, may induce the 
expression of class II RNR [34]. Hence, we hypothesize 
that the oxygen independence of class II RNR in addition 
to the stress present in the infectious environment favor 
the expression of this RNR class and the subsequent 
adaptation of P. aeruginosa to the intracellular lifestyle, 
which allows the formation of a bacterial reservoir and 
contributes to infection recurrence and chronicity.
Our study demonstrates the different pathophy-
siologies generated in different in vitro models of 
lung epithelium depending on the P. aeruginosa 
strain used. Therefore, the choice of bacterial strain 
is critical to properly study the type of infectious 
process with relevant translational outcomes. 
Furthermore, the heterogeneous expression of RNRs 
in the prokaryotic world opens a window in the 
treatment of infections. The exclusivity of class Ia 
RNR expression by humans allows the other RNR 
classes to be treated as antimicrobial targets. 
Different RNR classes have been postulated to be 
antimicrobial targets to combat infections. In this 
sense, science is moving toward the development of 
antimicrobial strategies against this enzyme [6,35]. In 
this work, we related class II RNR expression to the 
intracellular persistence of P. aeruginosa in different 
types of lung epithelial cells, which may contribute to 
the development of RNR-targeted strategies against 
the chronicity of this infection.
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